Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Nattermann

Showing results (51-60 of 159) with videos related to

Pageof 16
Sort By:
Zentralblatt Fur Chirurgie|August 2, 2018
[Outcomes after Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer]Dimitrios Pantelis, Philipp Lingohr, Robert Hueneburg, et al.
Endoscopy International Open|February 16, 2016
Colonoscopy detects significantly more flat adenomas than 3-tesla magnetic resonance colonography: a pilot trialRobert Hüneburg, Guido Kukuk, Jacob Nattermann, et al.
Cancers|December 16, 2020
Hereditary Diffuse Gastric Cancer: A Comparative Cohort Study According to Pathogenic Variant StatusTim Marwitz, Robert Hüneburg, Isabel Spier, et al.
Journal of Hepatology|August 29, 2012
Susceptibility to chronic hepatitis C virus infection is influenced by sequence differences in immunodominant CD8+ T cell epitopesSusanne Ziegler, Marianne Ruhl, Hannelore Tenckhoff, et al.
Journal of Hepatology|March 15, 2005
Serum antibodies against the hepatitis C virus E2 protein mediate antibody-dependent cellular cytotoxicity (ADCC)Jacob Nattermann, Angelika Maria Schneiders, Ludger Leifeld, et al.
Frontiers in Immunology|August 24, 2019
NK Cells in Ascites From Liver Disease Patients Display a Particular Phenotype and Take Part in Antibacterial Immune ResponsePhilipp Lutz, Hannah C Jeffery, Nicholas Jones, et al.
Journal of Hepatology|May 14, 2013
Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patientsAndreas Glässner, Marianne Eisenhardt, Pavlos Kokordelis, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 29, 2015
CD3(+)CD56(+) Natural Killer-Like T Cells Display Anti-HCV Activity but Are Functionally Impaired in HIV(+) Patients With Acute Hepatitis CPavlos Kokordelis, Benjamin Krämer, Christoph Boesecke, et al.
BMC Cancer|March 10, 2012
TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patientsChristian Körner, Katarina Riesner, Benjamin Krämer, et al.
Plos One|June 16, 2010
Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosisHenning W Zimmermann, Sebastian Seidler, Jacob Nattermann, et al.
Pageof 16

Showing results (51-60 of 159) with videos related to

Sort By:
Pageof 16
Zentralblatt Fur Chirurgie|August 2, 2018
[Outcomes after Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer]Dimitrios Pantelis, Philipp Lingohr, Robert Hueneburg, et al.
Endoscopy International Open|February 16, 2016
Colonoscopy detects significantly more flat adenomas than 3-tesla magnetic resonance colonography: a pilot trialRobert Hüneburg, Guido Kukuk, Jacob Nattermann, et al.
Cancers|December 16, 2020
Hereditary Diffuse Gastric Cancer: A Comparative Cohort Study According to Pathogenic Variant StatusTim Marwitz, Robert Hüneburg, Isabel Spier, et al.
Journal of Hepatology|August 29, 2012
Susceptibility to chronic hepatitis C virus infection is influenced by sequence differences in immunodominant CD8+ T cell epitopesSusanne Ziegler, Marianne Ruhl, Hannelore Tenckhoff, et al.
Journal of Hepatology|March 15, 2005
Serum antibodies against the hepatitis C virus E2 protein mediate antibody-dependent cellular cytotoxicity (ADCC)Jacob Nattermann, Angelika Maria Schneiders, Ludger Leifeld, et al.
Frontiers in Immunology|August 24, 2019
NK Cells in Ascites From Liver Disease Patients Display a Particular Phenotype and Take Part in Antibacterial Immune ResponsePhilipp Lutz, Hannah C Jeffery, Nicholas Jones, et al.
Journal of Hepatology|May 14, 2013
Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patientsAndreas Glässner, Marianne Eisenhardt, Pavlos Kokordelis, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 29, 2015
CD3(+)CD56(+) Natural Killer-Like T Cells Display Anti-HCV Activity but Are Functionally Impaired in HIV(+) Patients With Acute Hepatitis CPavlos Kokordelis, Benjamin Krämer, Christoph Boesecke, et al.
BMC Cancer|March 10, 2012
TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patientsChristian Körner, Katarina Riesner, Benjamin Krämer, et al.
Plos One|June 16, 2010
Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosisHenning W Zimmermann, Sebastian Seidler, Jacob Nattermann, et al.
Pageof 16